Couchbase's recent performance demonstrated strong revenue growth and improved profitability. The company operates in an attractive industry with room for growth. Management's guidance for FY25 is ...
Base editing—the genome editing technique that alters base pairs using a nuclease-deficient Cas9 fused to a deaminase—was found to restart fetal hemoglobin expression in sickle cell disease (SCD) ...
Hosted on MSN
Couchbase’s (NASDAQ:BASE) Q4: Beats On Revenue
Database as a service company Couchbase (NASDAQ: BASE) reported in Q4 CY2024, with sales up 9.6% year on year to $54.92 million. On the other hand, next quarter’s revenue guidance of $55.5 million was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results